By Ethan Covey
The Advisory Committee on Immunization Practices (ACIP) has broadened its recommendations regarding who should receive pre-exposure vaccination against Ebola virus disease to include two additional groups of people: healthcare personnel at special pathogens treatment centers, and laboratorians and support staff at Laboratory Response Network facilities.
The recommendations for the ERVEBO Ebola vaccine (Merck), which was approved by the FDA in December 2019, focus on adults 18 years